Orca Pharmaceuticals company

Orca Pharmaceuticals, a new biotechnology start-up focused on treating autoimmune diseases.
Funding is from BioMotiv, a Cleveland, Ohio based therapeutics accelerator affiliated with The Harrington Project, and the New York University Innovation Venture Fund.
The company, located in Oxford UK, is based on technology developed by inventors from New York University (NYU) in collaboration with the founders in the United Kingdom.
Technology: P4 Medicine
Industry: Personalized Medicine
Headquarters: Abingdon, Oxfordshire, United Kingdom
Founded Date: 2012
Employees Number: Undisclosed
Funding Status: N/A
Investors Number: 2
Total Funding: $1.3M
Estimated Revenue: Less than $1M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership